Home > Publications Database > Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease. > print |
001 | 164114 | ||
005 | 20240826165947.0 | ||
024 | 7 | _ | |a 10.3233/JAD-215416 |2 doi |
024 | 7 | _ | |a pmid:35275535 |2 pmid |
024 | 7 | _ | |a 1387-2877 |2 ISSN |
024 | 7 | _ | |a 1875-8908 |2 ISSN |
024 | 7 | _ | |a altmetric:124920905 |2 altmetric |
037 | _ | _ | |a DZNE-2022-00777 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Wolfsgruber, Steffen |0 P:(DE-2719)2810544 |b 0 |e First author |
245 | _ | _ | |a Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease. |
260 | _ | _ | |a Amsterdam |c 2022 |b IOS Press |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1710928856_2066 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a It is unclear whether subjective cognitive decline (SCD) is a relevant clinical marker of incipient Alzheimer's disease (AD) and future cognitive deterioration in individuals with a family history of AD (FHAD).To investigate the association of SCD with cross-sectional cerebrospinal fluid (CSF) AD biomarker levels and cognitive decline in cognitively normal older adults with or without a first-degree FHAD.We analyzed data from cognitively normal individuals with first-degree FHAD (n = 82 'AD relatives'; mean age: 65.7 years (SD = 4.47); 59% female) and a similar group of n = 236 healthy controls without FHAD from the DELCODE study. We measured SCD with an in-depth structured interview from which we derived a SCD score, capturing features proposed to increase likelihood of underlying AD ('SCD-plus score'). We tested whether higher SCD-plus scores were associated with more pathological CSF AD biomarker levels and cognitive decline over time and whether this association varied by group.AD relatives showed higher SCD-plus scores than healthy controls and more cognitive decline over time. Higher SCD-plus scores also related stronger to cognitive change and abnormal CSF AD biomarker levels in the AD relatives as compared to the healthy controls group.Quantification of specific SCD features can provide further information on the likelihood of early AD pathology and cognitive decline among AD relatives. FHAD and SCD appear as synergistically acting enrichment strategies in AD research, the first one as a permanent indicator of genetic risk, the latter one as a correlate of disease progression. |
536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a Alzheimer’s disease |2 Other |
650 | _ | 7 | |a cerebrospinal fluid |2 Other |
650 | _ | 7 | |a family history |2 Other |
650 | _ | 7 | |a subjective cognitive decline |2 Other |
650 | _ | 2 | |a Aged |2 MeSH |
650 | _ | 2 | |a Alzheimer Disease: pathology |2 MeSH |
650 | _ | 2 | |a Biomarkers: cerebrospinal fluid |2 MeSH |
650 | _ | 2 | |a Cognitive Dysfunction: psychology |2 MeSH |
650 | _ | 2 | |a Cross-Sectional Studies |2 MeSH |
650 | _ | 2 | |a Female |2 MeSH |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Male |2 MeSH |
650 | _ | 2 | |a Neuropsychological Tests |2 MeSH |
693 | _ | _ | |0 EXP:(DE-2719)DELCODE-20140101 |5 EXP:(DE-2719)DELCODE-20140101 |e Longitudinal Cognitive Impairment and Dementia Study |x 0 |
700 | 1 | _ | |a Kleineidam, Luca |0 P:(DE-2719)2812139 |b 1 |
700 | 1 | _ | |a Weyrauch, Anne Sophie |0 P:(DE-2719)9002221 |b 2 |u dzne |
700 | 1 | _ | |a Barkhoff, Miriam |0 P:(DE-2719)2812114 |b 3 |
700 | 1 | _ | |a Röske, Sandra |0 P:(DE-2719)2810395 |b 4 |
700 | 1 | _ | |a Peters, Oliver |0 P:(DE-2719)2811024 |b 5 |
700 | 1 | _ | |a Preis, Lukas |0 P:(DE-2719)9000703 |b 6 |
700 | 1 | _ | |a Gref, Daria |0 P:(DE-2719)9001704 |b 7 |
700 | 1 | _ | |a Spruth, Eike Jakob |0 P:(DE-2719)2812446 |b 8 |
700 | 1 | _ | |a Altenstein, Slawek |0 P:(DE-2719)2811720 |b 9 |
700 | 1 | _ | |a Priller, Josef |0 P:(DE-2719)2811122 |b 10 |
700 | 1 | _ | |a Fließbach, Klaus |0 P:(DE-2719)2811326 |b 11 |
700 | 1 | _ | |a Schneider, Anja |0 P:(DE-2719)2812035 |b 12 |
700 | 1 | _ | |a Wiltfang, Jens |0 P:(DE-2719)2811317 |b 13 |
700 | 1 | _ | |a Bartels, Claudia |0 P:(DE-2719)9000444 |b 14 |
700 | 1 | _ | |a Jessen, Frank |0 P:(DE-2719)2000032 |b 15 |
700 | 1 | _ | |a Maier, Franziska |0 P:(DE-HGF)0 |b 16 |
700 | 1 | _ | |a Düzel, Emrah |0 P:(DE-2719)2000005 |b 17 |
700 | 1 | _ | |a Metzger, Coraline |0 P:(DE-2719)9000443 |b 18 |
700 | 1 | _ | |a Glanz, Wenzel |0 P:(DE-2719)2811614 |b 19 |
700 | 1 | _ | |a Bürger, Katharina |0 P:(DE-2719)2811351 |b 20 |
700 | 1 | _ | |a Janowitz, Daniel |0 P:(DE-HGF)0 |b 21 |
700 | 1 | _ | |a Perneczky, Robert |0 P:(DE-2719)2812234 |b 22 |
700 | 1 | _ | |a Rauchmann, Boris Stephan |0 P:(DE-2719)9001808 |b 23 |
700 | 1 | _ | |a Kilimann, Ingo |0 P:(DE-2719)2810394 |b 24 |
700 | 1 | _ | |a Teipel, Stefan |0 P:(DE-2719)2000026 |b 25 |
700 | 1 | _ | |a Laske, Christoph |0 P:(DE-2719)2000055 |b 26 |
700 | 1 | _ | |a Munk, Matthias H |0 P:(DE-2719)9001516 |b 27 |
700 | 1 | _ | |a Roy, Nina |0 P:(DE-2719)2812341 |b 28 |
700 | 1 | _ | |a Spottke, Annika |0 P:(DE-2719)2811324 |b 29 |
700 | 1 | _ | |a Ramirez, Alfredo |0 P:(DE-2719)2812825 |b 30 |
700 | 1 | _ | |a Heneka, Michael T |0 P:(DE-2719)2000008 |b 31 |
700 | 1 | _ | |a Brosseron, Frederic |0 P:(DE-2719)2810593 |b 32 |
700 | 1 | _ | |a Wagner, Michael |0 P:(DE-2719)2000057 |b 33 |e Last author |
700 | 1 | _ | |a group, DELCODE study |b 34 |e Collaboration Author |
773 | _ | _ | |a 10.3233/JAD-215416 |g Vol. 87, no. 2, p. 545 - 555 |0 PERI:(DE-600)2070772-1 |n 2 |p 545 - 555 |t Journal of Alzheimer's disease |v 87 |y 2022 |x 1387-2877 |
856 | 4 | _ | |u https://pub.dzne.de/record/164114/files/DZNE-2022-00777_Restricted.pdf |
856 | 4 | _ | |u https://pub.dzne.de/record/164114/files/DZNE-2022-00777_Restricted.pdf?subformat=pdfa |x pdfa |
909 | C | O | |p VDB |o oai:pub.dzne.de:164114 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2810544 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2812139 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)9002221 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2812114 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2810395 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2811024 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 6 |6 P:(DE-2719)9000703 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 7 |6 P:(DE-2719)9001704 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)2812446 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2811720 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2811122 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 11 |6 P:(DE-2719)2811326 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2812035 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2811317 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 14 |6 P:(DE-2719)9000444 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-2719)2000032 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 17 |6 P:(DE-2719)2000005 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 18 |6 P:(DE-2719)9000443 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 19 |6 P:(DE-2719)2811614 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 20 |6 P:(DE-2719)2811351 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 22 |6 P:(DE-2719)2812234 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 23 |6 P:(DE-2719)9001808 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 24 |6 P:(DE-2719)2810394 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 25 |6 P:(DE-2719)2000026 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 26 |6 P:(DE-2719)2000055 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 27 |6 P:(DE-2719)9001516 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 28 |6 P:(DE-2719)2812341 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 29 |6 P:(DE-2719)2811324 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 30 |6 P:(DE-2719)2812825 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 31 |6 P:(DE-2719)2000008 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 32 |6 P:(DE-2719)2810593 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 33 |6 P:(DE-2719)2000057 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-04 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-18 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J ALZHEIMERS DIS : 2021 |d 2022-11-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-18 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-18 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-18 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2022-11-18 |
920 | 1 | _ | |0 I:(DE-2719)1011201 |k AG Wagner |l Neuropsychology |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1011101 |k Patient Studies Bonn |l Patient Studies Bonn |x 1 |
920 | 1 | _ | |0 I:(DE-2719)1811005 |k AG Endres |l Interdisciplinary Dementia Research |x 2 |
920 | 1 | _ | |0 I:(DE-2719)5000007 |k AG Priller |l Translational Neuropsychiatry |x 3 |
920 | 1 | _ | |0 I:(DE-2719)1011305 |k AG Schneider |l Translational Dementia Research (Bonn) |x 4 |
920 | 1 | _ | |0 I:(DE-2719)1410006 |k AG Wiltfang |l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases |x 5 |
920 | 1 | _ | |0 I:(DE-2719)1340013 |k KAP |l Cooperation Unit for Applied Prevention Research (KAP) |x 6 |
920 | 1 | _ | |0 I:(DE-2719)5000006 |k AG Düzel |l Clinical Neurophysiology and Memory |x 7 |
920 | 1 | _ | |0 I:(DE-2719)5000022 |k AG Dichgans |l Vascular Cognitive Impairment & Post-Stroke Dementia |x 8 |
920 | 1 | _ | |0 I:(DE-2719)1510100 |k AG Teipel |l Clinical Dementia Research (Rostock /Greifswald) |x 9 |
920 | 1 | _ | |0 I:(DE-2719)1240005 |k Core ICRU |l Core ICRU |x 10 |
920 | 1 | _ | |0 I:(DE-2719)1210000 |k AG Gasser |l Parkinson Genetics |x 11 |
920 | 1 | _ | |0 I:(DE-2719)1011401 |k Clinical Research Platform (CRP) |l Clinical Research Platform (CRP) |x 12 |
920 | 1 | _ | |0 I:(DE-2719)1011001 |k AG Klockgether |l Patient Studies |x 13 |
920 | 1 | _ | |0 I:(DE-2719)1011301 |k Biomarker |l Interventional Trials and Biomarkers in Neurodegenerative Diseases |x 14 |
920 | 1 | _ | |0 I:(DE-2719)5000034 |k Delcode |l Delcode |x 15 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1011201 |
980 | _ | _ | |a I:(DE-2719)1011101 |
980 | _ | _ | |a I:(DE-2719)1811005 |
980 | _ | _ | |a I:(DE-2719)5000007 |
980 | _ | _ | |a I:(DE-2719)1011305 |
980 | _ | _ | |a I:(DE-2719)1410006 |
980 | _ | _ | |a I:(DE-2719)1340013 |
980 | _ | _ | |a I:(DE-2719)5000006 |
980 | _ | _ | |a I:(DE-2719)5000022 |
980 | _ | _ | |a I:(DE-2719)1510100 |
980 | _ | _ | |a I:(DE-2719)1240005 |
980 | _ | _ | |a I:(DE-2719)1210000 |
980 | _ | _ | |a I:(DE-2719)1011401 |
980 | _ | _ | |a I:(DE-2719)1011001 |
980 | _ | _ | |a I:(DE-2719)1011301 |
980 | _ | _ | |a I:(DE-2719)5000034 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|